Survival analysis revealed that B-ALL patients with high cortactin and high HS1 expression had significantly shorter OS and increased frequency of relapse as compared to those with lower expression levels (P <0.01 for all). The gene discussed is CTTN; the disease is acute lymphoblastic leukemia.